Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
[PMID: 15119946] PubMed record related to this compound for laboratory literature review
Mary Jetha is the local principal investigator for a clinical trial of teplizumab, which is sponsored by Provention Bio Inc., with funding provided to the University of Alberta, unrelated to this work
Molecular pathology of nonsmall cell lung Cancer
McMahon, H
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
US$ 29.02
US$ 28.89
US$ 19.99
US$ 20.08
US$ 26.34
US$ 27.28
US$ 25.31
US$ 29.59
US$ 24.23
